Teladoc Health Inc (TDOC)’s Market Momentum: Closing Strong at 9.01, Down -3.12

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Teladoc Health Inc’s stock clocked out at $9.01, down -3.12% from its previous closing price of $9.30. In other words, the price has decreased by -$3.12 from its previous closing price. On the day, 4.36 million shares were traded. TDOC stock price reached its highest trading level at $9.41 during the session, while it also had its lowest trading level at $8.8335.

Ratios:

To gain a deeper understanding of TDOC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.59 and its Current Ratio is at 1.62. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 0.68.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 17, 2024, Reiterated its Hold rating but revised its target price to $10 from $8 previously.

On February 29, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $22.

On February 26, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $17.Leerink Partners initiated its Market Perform rating on February 26, 2024, with a $17 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 11 ’24 when Turitz Andrew bought 38,983 shares for $9.49 per share.

Kornwasser Laizer bought 29,516 shares of TDOC for $262,825 on Oct 09 ’24. On Oct 08 ’24, another insider, Trencher Daniel, who serves as the Former Officer of the company, bought 8,343 shares for $8.58 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1542674176 and an Enterprise Value of 2018786560. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.59 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 0.774 whereas that against EBITDA is 30.606.

Stock Price History:

Over the past 52 weeks, TDOC has reached a high of $22.54, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 9.87%, while the 200-Day Moving Average is calculated to be -26.92%.

Shares Statistics:

It appears that TDOC traded 5.94M shares on average per day over the past three months and 4503170 shares per day over the past ten days. A total of 171.22M shares are outstanding, with a floating share count of 168.55M. Insiders hold about 1.56% of the company’s shares, while institutions hold 80.82% stake in the company. Shares short for TDOC as of 1727654400 were 27640038 with a Short Ratio of 4.65, compared to 1724976000 on 26967959. Therefore, it implies a Short% of Shares Outstanding of 27640038 and a Short% of Float of 20.979999.

Most Popular